v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Aug. 03, 2025
Aug. 04, 2024
OPERATING ACTIVITIES    
Net income $ 179.4 $ 309.4
Adjustments to reconcile to net cash provided by operating activities:    
Depreciation and amortization 136.4 141.9
Equity in net income of unconsolidated affiliates (22.7) (24.1)
Deferred taxes (478.0) (7.3)
Stock-based compensation expense 26.0 26.9
Impairment of goodwill and other intangible assets 479.5 0.0
Other gain 0.0 (10.0)
Changes in operating assets and liabilities:    
Trade receivables, net (10.2) (91.4)
Other receivables 8.1 3.5
Inventories, net (198.3) (155.3)
Accounts payable, accrued expenses and deferred revenue 11.9 37.5
Prepaid expenses (38.5) 4.0
Other, net 48.1 (9.4)
Net cash provided by operating activities 141.7 225.7
INVESTING ACTIVITIES    
Purchases of property, plant and equipment (57.9) (75.4)
Proceeds from sale of Warner's, Olga and True&Co. women's intimates businesses 2.5 2.5
Purchases of investments held in rabbi trust (8.6) (3.0)
Proceeds from investments held in rabbi trust 5.0 0.4
Proceeds from cross-currency swap contracts (net investment hedges) 0.0 3.5
Net cash used by investing activities (59.0) (72.0)
FINANCING ACTIVITIES    
Net proceeds from short-term borrowings 0.0 8.3
Repayment of 2022 facilities (6.2) (5.9)
Net proceeds from settlement of awards under stock plans 1.4 7.3
Proceeds from senior notes, net of related fees 494.0 553.1
Repayment/redemption of senior notes (500.0) (561.7)
Cash dividends (3.9) (4.3)
Acquisition of treasury shares (577.0) (245.4)
Payments of finance lease liabilities (1.8) (2.2)
Net cash used by financing activities (593.5) (250.8)
Effect of exchange rate on cash and cash equivalents 11.6 (0.5)
Decrease in cash and cash equivalents (499.2) (97.6)
Cash and cash equivalents at beginning of period 748.0 707.6
Cash and cash equivalents at end of period $ 248.8 $ 610.0